Natural remedy use in a prospective cohort of breast cancer patients in southern Sweden

Acta Oncologica

Volumn 50, Issue 1, 2011, Pages 134-143

  Hietala, Maria ^a   Henningson, Maria ^a   Ingvar, Christian ^b   Jönsson, Per Ebbe ^c   Rose, Carsten ^b   Jernström, Helena ^a  

^a LUND UNIVERSITY   (Sweden)

^b LUND UNIVERSITY HOSPITAL   (Sweden)

^c HELSINGBORG HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; ANTINEOPLASTIC AGENT; MINERAL; TAMOXIFEN; VITAMIN;

ADULT; AGED; ALCOHOL CONSUMPTION; ALTERNATIVE MEDICINE; ARTICLE; BODY MASS; BREAST CANCER; CANCER HORMONE THERAPY; CANCER PATIENT; CIGARETTE SMOKING; COFFEE; CONTROLLED STUDY; DIET SUPPLEMENTATION; FEMALE; FOLLOW UP; FOOD FREQUENCY QUESTIONNAIRE; HUMAN; LIFESTYLE; MAJOR CLINICAL STUDY; MEDICINAL PLANT; NULLIPARA; POSTOPERATIVE PERIOD; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; QUESTIONNAIRE; SWEDEN;

AGED; ALCOHOL DRINKING; ANTIDEPRESSIVE AGENTS; ANTINEOPLASTIC AGENTS; BREAST NEOPLASMS; CHEMOTHERAPY, ADJUVANT; COMPLEMENTARY THERAPIES; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; KAPLAN-MEIER ESTIMATE; MIDDLE AGED; NATUROPATHY; NEOADJUVANT THERAPY; ODDS RATIO; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; QUESTIONNAIRES; SWEDEN; VITAMINS;

EID: 78650567447     PISSN: 0284186X     EISSN: 1651226X     Source Type: Journal    
DOI: 10.3109/0284186X.2010.484812     Document Type: Article

References (25)

1. Adler SR, Fosket JR. Disclosing complementary and alternative medicine use in the medical encounter: A qualitative study in women with breast cancer. J Fam Pract 1999; 48:453-8.
2. Gerber B, Scholz C, Reimer T, Briese V, Janni W. Complementary and alternative therapeutic approaches in patients with early breast cancer: A systematic review. Breast Cancer Res Treat 2006;95:199-209.
3. Sparreboom A, Cox MC, Acharya MR, Figg WD. Herbal remedies in the United States: Potential adverse interactions with anticancer agents. J Clin Oncol 2004;22:2489-503. (Pubitemid 41115408)
4. Jacobson JS, Workman SB, Kronenberg F. Research on complementary/ alternative medicine for patients with breast cancer: A review of the biomedical literature. J Clin Oncol 2000;18:668-83. (Pubitemid 30078549)
5. Greenlee H, Hershman DL, Jacobson JS. Use of antioxidant supplements during breast cancer treatment: A comprehensive review. Breast Cancer Res Treat 2009;115: 437-52.
6. Bardia A, Barton DL, Prokop LJ, Bauer BA, Moynihan TJ. Effi cacy of complementary and alternative medicine therapies in relieving cancer pain: A systematic review. J Clin Oncol 2006;24:5457-64. (Pubitemid 46623180)
7. Burstein HJ, Gelber S, Guadagnoli E, Weeks JC. Use of alternative medicine by women with early-stage breast cancer. N Engl J Med 1999;340:1733-9. (Pubitemid 29252602)
8. DiGianni LM, Kim HT, Emmons K, Gelman R, Kalkbrenner KJ, Garber JE. Complementary medicine use among women enrolled in a genetic testing program. Cancer Epidemiol Biomarkers Prev 2003;12:321-6. (Pubitemid 36427992)
9. Greenlee H, Kwan ML, Ergas IJ, Sherman KJ, Krathwohl SE, Bonnell C, et al. Complementary and alternative therapy use before and after breast cancer diagnosis: The Pathways Study. Breast Cancer Res Treat 2009;117:653-65.
10. NCCAM. National Center for Complementary and Alternative Medicine. 2009 [updated 2009 Jan 16; cited 2009 Jan 16]; Available from: Http://nccam.nih.gov/ health/whatiscam/ overview.htm.
11. Pedersen CG, Christensen S, Jensen AB, Zachariae R. Prevalence, socio-demographic and clinical predictors of post-diagnostic utilisation of different types of complementary and alternative medicine (CAM) in a nationwide cohort of Danish women treated for primary breast cancer. Eur J Cancer 2009;45:3172-81.
12. Nilsson M, Trehn G, Asplund K. Use of complementary and alternative medicine remedies in Sweden. A populationbased longitudinal study within the northern Sweden MONICA Project. Multinational Monitoring of Trends and Determinants of Cardiovascular Disease. J Intern Med 2001;250:225-33.
13. Malekzadeh F, Rose C, Ingvar C, Jernström H. [Natural remedies and hormone preparations-potential risk for breast cancer patients. A study surveys the use of agents which possibly counteract with the treatment]. Lakartidningen 2005;102:3226 - 8, 30-1. (Pubitemid 41633348)
14. DiGianni LM, Garber JE, Winer EP. Complementary and alternative medicine use among women with breast cancer. J Clin Oncol 2002;20(Suppl 18):S34 - 8.
15. Rakovitch E, Pignol JP, Chartier C, Ezer M, Verma S, Dranitsaris G, et al. Complementary and alternative medicine use is associated with an increased perception of breast cancer risk and death. Breast Cancer Res Treat 2005;90: 139-48. (Pubitemid 40568897)
16. Nowack R. Review article: Cytochrome P450 enzyme, and transport protein mediated herb-drug interactions in renal transplant patients: Grapefruit juice, St John's Wort - and beyond! Nephrology (Carlton) 2008;13:337-47. (Pubitemid 351668338)
17. Myers CD, Jacobsen PB, Huang Y, Frost MH, Patten CA, Cerhan JR, et al. Familial and perceived risk of breast cancer in relation to use of complementary medicine. Cancer Epidemiol Biomarkers Prev 2008;17:1527-34.
18. Boivin J, Schmidt L. Use of complementary and alternative medicines associated with a 30% lower ongoing pregnancy/ live birth rate during 12 months of fertility treatment. Hum Reprod 2009;24:1626-31.
19. Bair YA, Gold EB, Zhang G, Rasor N, Utts J, Upchurch DM, et al. Use of complementary and alternative medicine during the menopause transition: Longitudinal results from the Study of Women's Health Across the Nation. Menopause 2008;15:32-43.
20. Kupferer EM, Dormire SL, Becker H. Complementary and alternative medicine use for vasomotor symptoms among women who have discontinued hormone therapy. J Obstet Gynecol Neonatal Nurs 2009;38:50-9.
21. Rodriguez-Antona C, Ingelman-Sundberg M. Cytochrome P450 pharmacogenetics and cancer. Oncogene 2006;25: 1679-91.
22. Kirchheiner J, Brosen K, Dahl ML, Gram LF, Kasper S, Roots I, et al. CYP2D6 and CYP2C19 genotype-based dose recommendations for antidepressants: A fi rst step towards subpopulation-specifi c dosages. Acta Psychiatr Scand 2001; 104:173-92. (Pubitemid 32762271)
23. Desta Z, Ward BA, Soukhova NV, Flockhart DA. Comprehensive evaluation of tamoxifen sequential biotransformation by the human cytochrome P450 system in vitro: Prominent roles for CYP3A and CYP2D6. J Pharmacol Exp Ther 2004;310:1062-75. (Pubitemid 39108928)
24. Stearns V, Johnson MD, Rae JM, Morocho A, Novielli A, Bhargava P, et al. Active tamoxifen metabolite plasma concentrations after coadministration of tamoxifen and the selective serotonin reuptake inhibitor paroxetine. J Natl Cancer Inst 2003;95:1758-64. (Pubitemid 38008898)
25. Menendez JA, Lupu R, Colomer R. Exogenous supplementation with omega-3 polyunsaturated fatty acid docosahexaenoic acid (DHA; 22:6n-3) synergistically enhances taxane cytotoxicity and downregulates Her-2/neu (c-erbB-2) oncogene expression in human breast cancer cells. Eur J Cancer Prev 2005;14:263-70. (Pubitemid 40789954)